Keywords: novartis, submits, xolair, japanese, clearance, swiss, drug

Novartis submits Xolair for Japanese clearance

Article | 03 July 2006

Print This

Swiss drug major Novartis has submitted an application to the Japanese health authorities for the approval of Xolair (omalizumab), its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in